Author

Yuki Kataoka

Taiho Pharmaceutical (Japan)ORCID 0000-0001-5194-654XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Research Focus:cell signaling & trafficking· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Eiji OkiiD· 3 shared Hiroaki OchiiwaiD· 3 shared Hiroyuki KitaoiD· 3 shared Makoto IimoriiD· 3 shared Takeshi WakasaiD· 3 shared Yoshihiko MaeharaiD· 3 shared Kentaro NonakaiD· 2 shared Koji AndoiD· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

Eiji OkiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologybioRxivPreprintMay 9, 2026

Temporal regulation of G2 phase avoids therapy-induced senescence caused by DNA replication stress-inducing drugs and provides synergistic cytotoxicity

Kentaro Nonaka, Takeshi Wakasa, Hiroaki Ochiiwa…·Makoto Iimori

This study shows that shortening the G2 phase enhances cell death from DNA replication stress-inducing drugs, regardless of p53 status.

DOI 10.64898/2026.05.06.723184

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 3, 2025

IAP antagonists potentiate TNFα-triggered apoptosis but selectively eliminate senescent tumor cells independently of TNFα

Hiroaki Ochiiwa, Takeshi Wakasa, Yuki Kataoka…·Hiroyuki Kitao

This study shows IAP antagonists induce apoptosis in senescent tumor cells both with and without TNF, suggesting they can eliminate TIS cells and sensitize non-senescent cells through TNF.

1 citation

humanexperimental assay

𝕏 PostBluesky

Cell BiologyCell Death DiscoveryPeer-reviewedJul 2, 2024

The anti-tumor effect of trifluridine via induction of aberrant mitosis is unaffected by mutations modulating p53 activity

Takeshi Wakasa, Kentaro Nonaka, Akihito Harada…·Hiroyuki Kitao

This study shows that trifluridine induces aberrant mitosis and cytotoxicity in both p53-null and p53-GOF mutant cells, independent of p53 function.

4 citations

humanDNA methylation

𝕏 PostBluesky